BSX · Earnings call · 2026Q3T · Full report

Geographic Revenue Performance

BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 25 · Surprise 32

In Q3 2026, U.S. operational sales were flat year over year, with performance driven by IC, IoE, and neuromodulation. Europe, Middle East, and Africa grew 6% operationally. Asia Pacific declined 1% operationally, reflecting the cyber incident and pricing pressure in China. Management expects China market growth to moderate to single digits as VBP and other pricing impacts affect multiple businesses.